Clinical Trial Update: Quitting Matters Human Immunodeficiency Virus Hybrid Trial [NA]

View source ↗

Summary

This document is a clinical trial update for the Quitting Matters HIV hybrid trial, a smoking-cessation study that is currently recruiting at Wake Forest Univer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection
• Tobacco Use Disorder

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Tobacco, Tobacco Abstinence | NA | Status: RECRUITING